ORTHOVISC®

TEXT SIZE  

Decrease Font SizeReset Font SizeIncrease Font Size

Managed Care and Reimbursement Support Services

 

Physician Locator

Help patients locate you. Sign up to be
listed in the physician locator now.

        CLICK HERE >>

Patient Education Seminars

Learn more about patient
education seminars.
        CLICK HERE >>

    How to order ORTHOVISC®

    DePuy Mitek, Inc. is the exclusive marketer and distributor of ORTHOVISC® in the United States. Physicians can order ORTHOVISC® directly from DePuy Mitek Customer Service (800-382-4682) to treat patients with Medicare or Private Insurance.

    Physicians may also write a prescription for ORTHOVISC® and have it filled through a pharmacy. To verify patient coverage for an ORTHOVISC® prescription, contact the patient's Private Pay insurance carrier or ORTHOVISCline at 866-633-VISC (8472) for assistance.

    ORTHOVISC® is supplied as a sterile-filled solution, in a single-use syringe, sealed in a sterile pouch inside a carton. The ORTHOVISC® syringe components contain no latex.

    ORTHOVISC® injections occur in a physician's office in a series of intra-articular injections 7 days apart for a total of 3 injections over a 15-day period (days 1, 8 and 15) for 3 consecutive weeks.

    Each syringe contains the following in a 2 mL dose:

    • HyaluronanHyaluronan/Hyaluronate
      A substance found naturally in joint fluid that acts as a shock absorber and lubricant in the knee joint and is necessary for the joint to function properly.
    		 30 mg
    • Sodium Chloride
    		 18 mg
    • Water for Injection
    		 q.s. up to 2.0 mL
    EMAIL THIS PAGEEMAIL THIS PAGE         PRINT PAGEPRINT PAGE

    This site is published by DePuy Mitek, Inc., which is solely responsible for its contents.
    It is intended for healthcare professionals in the U.S. and contains U.S. based product information only.
    ORTHOVISC® is manufactured by and is a registered trademark of Anika Therapeutics, Inc. Distributed by DePuy Mitek, Inc.

    © DePuy Mitek, Inc. 2005 - 2010

    AN OFFICIAL HEALTH AND FITNESS PROVIDER

    Important Safety Information

    ORTHOVISC® is indicated in the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g. acetaminophen. In clinical studies, the most commonly reported adverse events were arthralgia, back pain, and headache. Other side effects included local injection site adverse events.

    ORTHOVISC® is contraindicated in patients with known hypersensitivity to hyaluronate formulations or known hypersensitivity (allergy) to gram positive bacterial proteins. ORTHOVISC® should not be injected in patients with infections or skin diseases in the area of the injection site or joint. Strict aseptic technique should be used. The effectiveness of more than 1 course has not been established.